Improving the Care of Patients Who Have Treatment-Resistant Depression: The Promise of the PCORnet Mood Network
Year: 2015
Type: article
Institution: Massachusetts General Hospital
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: American Foundation for Suicide Prevention, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Massachusetts General Hospital, Patient-Centered Outcomes Research Institute, Teva Pharmaceutical Industries, International OCD Foundation, Brandeis University, Sunovion, National Alliance for Research on Schizophrenia and Depression, Massachusetts Medical Society, J. Willard and Alice S. Marriott Foundation, Mylan, International Bipolar Foundation, University of Oxford, H. Lundbeck A/S, National Institutes of Health, Agency for Healthcare Research and Quality, Genentech, National Institute of Mental Health
Award: G2075957719
OpenAlex ID: W1998699936